These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
506 related articles for article (PubMed ID: 8890659)
1. Cryptosporidiosis among patients infected with human immunodeficiency virus. Factors related to symptomatic infection and survival. Colford JM; Tager IB; Hirozawa AM; Lemp GF; Aragon T; Petersen C Am J Epidemiol; 1996 Nov; 144(9):807-16. PubMed ID: 8890659 [TBL] [Abstract][Full Text] [Related]
2. Biliary cryptosporidiosis in HIV-infected people after the waterborne outbreak of cryptosporidiosis in Milwaukee. Vakil NB; Schwartz SM; Buggy BP; Brummitt CF; Kherellah M; Letzer DM; Gilson IH; Jones PG N Engl J Med; 1996 Jan; 334(1):19-23. PubMed ID: 7494565 [TBL] [Abstract][Full Text] [Related]
3. Endemic cryptosporidiosis and exposure to municipal tap water in persons with acquired immunodeficiency syndrome (AIDS): a case-control study. Aragón TJ; Novotny S; Enanoria W; Vugia DJ; Khalakdina A; Katz MH BMC Public Health; 2003 Jan; 3():2. PubMed ID: 12515584 [TBL] [Abstract][Full Text] [Related]
4. Changes in AIDS survival time in two San Francisco cohorts of homosexual men, 1983 to 1993. Osmond D; Charlebois E; Lang W; Shiboski S; Moss A JAMA; 1994 Apr; 271(14):1083-7. PubMed ID: 7908703 [TBL] [Abstract][Full Text] [Related]
5. Predictors of mortality among HIV-infected women in Kigali, Rwanda. Lindan CP; Allen S; Serufilira A; Lifson AR; Van de Perre P; Chen-Rundle A; Batungwanayo J; Nsengumuremyi F; Bogaerts J; Hulley S Ann Intern Med; 1992 Feb; 116(4):320-8. PubMed ID: 1733389 [TBL] [Abstract][Full Text] [Related]
6. Mortality Risk After AIDS-Defining Opportunistic Illness Among HIV-Infected Persons--San Francisco, 1981-2012. Djawe K; Buchacz K; Hsu L; Chen MJ; Selik RM; Rose C; Williams T; Brooks JT; Schwarcz S J Infect Dis; 2015 Nov; 212(9):1366-75. PubMed ID: 26044289 [TBL] [Abstract][Full Text] [Related]
7. Short report: asymptomatic Cryptosporidium hominis infection among human immunodeficiency virus-infected patients in Tanzania. Houpt ER; Bushen OY; Sam NE; Kohli A; Asgharpour A; Ng CT; Calfee DP; Guerrant RL; Maro V; Ole-Nguyaine S; Shao JF Am J Trop Med Hyg; 2005 Sep; 73(3):520-2. PubMed ID: 16172475 [TBL] [Abstract][Full Text] [Related]
8. Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy. Sparano JA; Hu X; Wiernik PH; Sarta C; Reddy DM; Hanau L; Henry DH J Natl Cancer Inst; 1997 Feb; 89(4):301-7. PubMed ID: 9048834 [TBL] [Abstract][Full Text] [Related]
9. Impact of socioeconomic status on survival with AIDS. Katz MH; Hsu L; Lingo M; Woelffer G; Schwarcz SK Am J Epidemiol; 1998 Aug; 148(3):282-91. PubMed ID: 9690366 [TBL] [Abstract][Full Text] [Related]
10. Cryptosporidiosis among HIV-infected persons in the Niger Delta of Nigeria. Erhabor O; Obunge O; Awah I Niger J Med; 2011; 20(3):372-5. PubMed ID: 21970221 [TBL] [Abstract][Full Text] [Related]
11. Cryptosporidiosis and microsporidiosis in ugandan children with persistent diarrhea with and without concurrent infection with the human immunodeficiency virus. Tumwine JK; Kekitiinwa A; Bakeera-Kitaka S; Ndeezi G; Downing R; Feng X; Akiyoshi DE; Tzipori S Am J Trop Med Hyg; 2005 Nov; 73(5):921-5. PubMed ID: 16282304 [TBL] [Abstract][Full Text] [Related]
12. Logarithmic relationship of the CD4 count to survival in patients with human immunodeficiency virus infection. Nightingale SD; Jockusch JD; Haslund I; Cal SX; Peterson DM; Loss SD Arch Intern Med; 1993 Jun; 153(11):1313-8. PubMed ID: 8099477 [TBL] [Abstract][Full Text] [Related]
13. Risk factors, seasonality, and trends of cryptosporidiosis among patients infected with human immunodeficiency virus. Inungu JN; Morse AA; Gordon C Am J Trop Med Hyg; 2000 Mar; 62(3):384-7. PubMed ID: 11037782 [TBL] [Abstract][Full Text] [Related]
14. Re: "Cryptosporidiosis among patients infected with human immunodeficiency virus: factors related to symptomatic infection and survival". Clark RA; Bessinger R Am J Epidemiol; 1997 Aug; 146(4):358-9. PubMed ID: 9270415 [No Abstract] [Full Text] [Related]
15. Impact of opportunistic disease on survival in patients with HIV infection. Chaisson RE; Gallant JE; Keruly JC; Moore RD AIDS; 1998 Jan; 12(1):29-33. PubMed ID: 9456252 [TBL] [Abstract][Full Text] [Related]
16. Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda. Whalen CC; Nsubuga P; Okwera A; Johnson JL; Hom DL; Michael NL; Mugerwa RD; Ellner JJ AIDS; 2000 Jun; 14(9):1219-28. PubMed ID: 10894287 [TBL] [Abstract][Full Text] [Related]
17. Gender-specific differences in the natural history, clinical features, and socioeconomic status of HIV-infected patients: experience of a treatment centre in Vienna. Armbruster C; Kriwanek S; Vorbach H Wien Klin Wochenschr; 2000 Sep; 112(17):754-60. PubMed ID: 11042904 [TBL] [Abstract][Full Text] [Related]
18. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group. Chaisson RE; Keruly J; Richman DD; Moore RD Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373 [TBL] [Abstract][Full Text] [Related]
19. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic. Ives NJ; Gazzard BG; Easterbrook PJ J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320 [TBL] [Abstract][Full Text] [Related]
20. Disease progression and survival in HIV-1-infected Africans in London. Del Amo J; Petruckevitch A; Phillips A; Johnson AM; Stephenson J; Desmond N; Hanscheid T; Low N; Newell A; Obasi A; Paine K; Pym A; Theodore CM; De Cock KM AIDS; 1998 Jul; 12(10):1203-9. PubMed ID: 9677170 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]